CF PharmTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2652?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,626,106	0.395%
Public Companies	15,165,653	3.68%
VC/PE Firms	26,058,641	6.33%
General Public	41,198,000	10%
Private Companies	125,014,434	30.3%
Institutions	202,915,553	49.3%

Dilution of Shares: 2652 only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 75.34% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.34%	Pyramid Investment Limited	26,129,045	HK$750.9m	0%	no data
6.33%	SDIC Innovation Investment Management Co., Ltd.	26,058,641	HK$748.9m	0%	4.45%
5.82%	Gentiana International Corporation Limited	23,964,547	HK$688.7m	0%	no data
5.11%	Suzhou Minmei Investment Management Enterprise esop	21,063,828	HK$605.4m	0%	no data
4.93%	CICC Capital Management Co., Ltd.	20,307,384	HK$583.6m	0%	6.41%
4.69%	Suzhou Yuanchen Enterprise Management Center (Limited Partnership)	19,329,782	HK$555.5m	0%	no data
3.68%	Beijing SL Pharmaceutical Co., Ltd.	15,165,653	HK$435.9m	0%	no data
3.68%	Shanghai Jucheng Venture Capital Partnership Enterprise (Limited Partnership)	15,165,653	HK$435.9m	0%	no data
3.29%	Jiangsu Zhaoyin Industry Fund Management Co., Ltd.	13,545,187	HK$389.3m	0%	no data
3.11%	Suzhou Oriza Holdings Co., Ltd.	12,797,494	HK$367.8m	0%	3.25%
2.92%	Shanghai Lianxin Capital Management Co., Ltd.	12,048,878	HK$346.3m	0%	38.05%
2.62%	Suzhou Meimin Enterprise Management Center (Limited Partnership)	10,791,401	HK$310.1m	0%	no data
2.56%	Suzhou Wolun Enterprise Management Center esop	10,563,854	HK$303.6m	0%	no data
2.39%	Shanghai Jinshahe Venture Capital Partnership (Limited Partnership)	9,851,194	HK$283.1m	0%	no data
2.23%	Zhuhai Longmen Changfeng Investment Partnership	9,205,620	HK$264.6m	0%	no data
2.11%	YuanMing Capital	8,677,133	HK$249.4m	0%	100.0%
2.05%	Unique Classic Limited	8,434,214	HK$242.4m	0%	no data
1.79%	CCB Principal Asset Management Co., Ltd.	7,364,496	HK$211.7m	0%	0.38%
1.74%	Shanghai Hanren Investment Holdings Co., Ltd.	7,164,180	HK$205.9m	0%	100.0%
1.46%	ShenZhen GTJA Investment Group Co., Ltd	6,024,439	HK$173.1m	0%	10.68%
1.46%	Anhui Xinbao Costone Asset Management Co., Ltd.	6,024,439	HK$173.1m	0%	10.74%
1.46%	Suzhou Longmen No. 1 Pharmaceutical Investment Partnership	6,024,439	HK$173.1m	0%	no data
1.34%	Shanghai Jinpu Guotiao Merger Equity Investment Fund Partnership	5,532,910	HK$159.0m	0%	no data
1.33%	Jiangsu Jiequan GTJA Medical Industry Investment Fund (Limited Partnership)	5,470,464	HK$157.2m	0%	no data
0.89%	Shanghai Jianli Investment Partnership (Limited Partnership)	3,682,248	HK$105.8m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/22 00:25
End of Day Share Price	2025/10/22 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CF PharmTech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.